Pengaruh Jenis Terapi, Outcome klinik dan Karakteristik Pasien terhadap Kualitas Hidup Pasien

Diabetes Melitus Tipe 2 di Rumah Sakit Pratama Yogyakarta

Monika Wisda Herisman, Dr. Tri Murti Andayani, Sp. FRS., Apt
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

DAFTAR PUSTAKA

ADA, 2015, Classification and Diagnosis of Diabetes, Diabetes Care, 38, 8-16.

ADA, 2018a, Classification and Diagnosis of Diabetes: Standards of Medical Care

in Diabetes, Diabetes Care, 41 (1), 13-27.

ADA, 2018b, Glycemic Targets: Standards of Medical Care on Diabetes, Diabetes

Care, 41 (1), 55–64.

ADA, 2018c, The Cost of Diabetes, http://www.diabetes.org/advocacy/news-

events/cost-of-diabetes.html, 26 Juni 2018.

ADA, 2018d, Pharmacologic Aproaches to Glycemic Treatment: Standards of

Medical Care in Diabetes, Diabetes Care, 41 (1), S73–S85.

Adibe, M.O., Aguwa, C.N., Ukwe, C.V., 2013, Cost Utility Analysis of
Pharmaceutical Care Intervention Versus Usual Care in Management of
Nigeria Patient with Type 2 Diabetes, cit. Khoiriyah, S. D. & Lestari, K.,
2018, Review Artikel: Kajian Farmakoekonomi Yang Mendasari Pemilihan
Pengobatan di Indonesia, Farmaka., 16 (3), 134 – 145.

Adikusuma, W., Perwitasari, D.A., Supadmi, W., 2018, Evaluasi Kualitas Hidup
Pasien Diabetes Melitus Tipe 2 Rumah Sakit Umum PKU Muhammadiyah
Bantul, Prosiding “Simposium Nasional Peluang dan Tantangan Obat
Tradisional dalam Pelayanan Kesehatan Formal”, 32-39.

Adriaanse, M.C., Drewes, H.W., Heide, I.V.D., Struijs, J.N., Baan, C.A., 2016, The
Impact of Comorbid Chronic Conditions on Quality of Life in Type 2
Diabetes Patients, Qual Life Res., 25, 175-182.

Agarwal, A.A., Jadhav1, P.R., Deshmukh, Y.A., 2014, Prescribing Pattern and
Efficacy of Anti‑Diabetic Drugs, Jurnal of Basic and Clinical Pharmacy, 3
(5), 79-83.

Al Hayek, A.A., Robert, A.A., Al Saeed, A., Alzaid, A.A., Al Sabaan, F.S., 2014,
Factors Associated with Health Realited Quality of Life among Saudi
Patients with Type 2 Diabetes Mellitus: A Cross Sectional Survey, Diabetes
and Metabolism Journal, 38, 220-229.

Amelia, R., Lelo, A., Lindarto, D., Mutiara, E., 2018, Quality of Life and Glycemic
Profile of Type 2 Diabetes Mellitus Patients of Indonesian: a Descriptive
Study, IOP Conf. Series: Earth and Environmental Science, 125, 012171.

Anonim, 2017, EQ-5D, https://euroqol.org/eq-5d-instruments, 25 Oktober 2018.

82
 Pengaruh Jenis Terapi, Outcome klinik dan Karakteristik Pasien terhadap Kualitas Hidup Pasien
Diabetes Melitus Tipe 2 di Rumah Sakit Pratama Yogyakarta 83
Monika Wisda Herisman, Dr. Tri Murti Andayani, Sp. FRS., Apt
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

Anonim, 2018, Diabetes Mellitus Type 2 in Adults, DynaMed, pp. 1–71.

Andayani, T.M., 2013, Farmakoekonomi, Prinsip dan Metodologi, Bursa Ilmu,

Yogyakarta.

Arifin, B., Idrus, L.R., Van Asselt, A.D.I., Purba, F.D., Perwitasari, D.A., Thobari,
J.A., Cao, Q., Krabbe, P.F.M., Postma, M.J., 2019, Health-Related Quality
of Life in Indonesian Type 2 Diabetes Mellitus Outpatients Measured with
the Bahasa Version of EQ-5D, Quality of Life Research.

Charlson, M.E., Ales, K.A., Pomper, P, MacKenzie, C.R., 1987, A New Method of
Classification of Prognostic Comorbidity for Longitudinal Studies
Development and Validaation, J Chron Disease, 40 (5), 373-383.

Charlson, M.E., Charlson, R.E., Briggs, W., Hollenberg, J., 2007, Can Disease
Management Target Patients Most Likely to Generate High Costs? The
Impact of Comorbidity, J Gen Intern Med, 22 (4), 464-469.

Cho, N.H., Shaw, J.E., Karuranga, S., Huang, Y., Fernandes, J.D.R., Ohlrogge,
A.W., Malanda, B., 2018, IDF Diabetes Atlas: Global Estimates of Diabetes
Prevalence for 2017 and Projections for 2045, Diabetes Research and
Clinical Practice, 138, 271-281

Coons, S.J., 2005, Health Outcomes and Quality of Life, in Dipiro, J.T (Eds),
Pharmacotherapy A Pathophysiologic Approach, sixth edition, 1-5,
Appleton and Lange, Standford Connecticut.

Cramer, J.A., 2004, A Systematic Review of Adherence With Medications for

Diabetes, Diabetes Care, 27, 1218–1224.

Daher, A.M., AlMashoor, S.A.H., Winn, T., 2015, Glycaemic Control and Quality
of Life Among Ethnically Diverse Malaysian Diabetic Patients, Qual Life
Res, 24, 951-958.

De Grauw, et al., 2001, Insulin Therapy in Poorly Controlled Type 2 Diabetic

Patients: Does it Affect Quality of Life?, Br. J. Gen. Pract., 51 (468), 527-
532.

Departemen Kesehatan RI., 2005, Pharmaceutical Care Untuk Penyakit Diabetes

Melitus, Jakarta, Direktorat Bina Farmasi Komunitas dan Klinik Direktorat
Jendral bina Kefarmasian dan Alat Kesehatan.

Departemen Kesehatan RI, 2017, Profil Kesehatan Provinsi, Daerah Istimewa

Yogyakarta,
www.depkes.go.id/resources/download/profil/PROFIL_KES./14_DIY_20
17.pdf, Departemen Kesehatan Republik Indonesia, Jakarta.
 Pengaruh Jenis Terapi, Outcome klinik dan Karakteristik Pasien terhadap Kualitas Hidup Pasien
Diabetes Melitus Tipe 2 di Rumah Sakit Pratama Yogyakarta 84
Monika Wisda Herisman, Dr. Tri Murti Andayani, Sp. FRS., Apt
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

Didarloo, A., Alizadeh, M., 2016, Health-Related Quality of Life and its
Determinants Among Women With Diabetes Mellitus: A Cross-Sectional
Analysis, Nurs Midwifery Stud., 5 (1):e28937.

Diener, E., & Suh, E. M., 2000, National difference in subjective well-being, cit.
Wahyuni, Y., Nursiswati, Anna, A., 2014, Kualitas Hidup Berdasarkan
Karakteristik Pasien Diabetes Melitus Tipe 2, Jurnal Keperawatan
Padjadjaran, 2 (1), 25-34.

DiPiro, J.T., Wells, B.G., Schwinghammer, T.L., dan DiPiro, C.V., 2015,
Pharmacotherapy Handbook, 9th Ed., 161-175, McGraw-Hill Education,
USA.

Fal, A.M., Jankowskaa, B., Uchmanowicz, I., Sen, M., Panaszek, B., Polanski, J.,
2011, Type 2 Diabetes Quality of Life Patients Treated with Insulin and
Oral Hypoglycemic Medication, Acta Diabetol, 48, 237–242.

Fatimah, R.N., 2015, Diabetes Melitus Tipe 2, J MAJORITY, 4 (5), 93-101.

George, C.M., Bruijn, L.L., 2015, Management of Blood Glucose with Noninsulin
Therapies in Type 2 Diabetes, American Academy of Family Physicians, 92
(1), 27-34.

International Diabetes Federation (IDF), 2017, IDF Diabetes Atlas, 8th edition.

Javanbakht, M., Abolhasani, F., Mashayekhi, A., Baradaran, H. R., Noudeh, Y. J.,
2012, Health Related Quality of Life in Patients with Type 2 Diabetes
Mellitus in Iran: A National Survey, PLOS ONE, 7 (8), 1-9.

Khoiriyah, S.D. & Lestari, K., 2018, Review Artikel: Kajian Farmakoekonomi
Yang Mendasari Pemilihan Pengobatan di Indonesia, Farmaka., 16 (3), 134
– 145.

Kurniawan, I., 2010, Diabetes Melitus Tipe 2 pada Usia Lanjut, Maj Kedokt Indon,
60 (12), 576 – 584.

Lee, W.J., Song, K.H., Noh,J.H.,Choi, Y.J., Jo, Min-Woo, 2012, Health-Related
Quality of Life Using the EuroQol 5D Questionnaire in Korean Patients
with Type 2 Diabetes, J Korean Med Sci, 27, 255-260.

Lu, Y., Wang, N., Chen, Y., Nie, X., Li, Q., Han, B., Chen, Y., Xia, F., Cang, Z.,
Lu, M., Meng, Y., and Lu, Y., 2017, Health-Related Quality of Life in Type-
2 Diabetes Patients: A Cross-Sectional Study in East China, BMC
Endocrine Disorders, 17 (38), 1-7.
 Pengaruh Jenis Terapi, Outcome klinik dan Karakteristik Pasien terhadap Kualitas Hidup Pasien
Diabetes Melitus Tipe 2 di Rumah Sakit Pratama Yogyakarta 85
Monika Wisda Herisman, Dr. Tri Murti Andayani, Sp. FRS., Apt
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

Maruthur, N. M., Tseng, E., Hutfless, S., Wilson, L.M., Suarez-Cuervo, C., Berger,
Z., Chu, Y., Iyoha, E., Segal, J.B., Bolen, S., 2016, Diabetes Medications as
Monotherapy or Metformin based Combination Therapy for Type 2
Diabetes: A Systematic Review and Meta-Analysis, Annals of Internal
Medicine, 164 (11), 740–751.

Nathan, D.M., Buse, J.B., Davidson, M.B., Ferrannini, E., Holman, R.R., Sherwin,
R., Zinman, B., 2009, Medical Manajement of Hyperglycaemia in Type 2
Diabetes Mellitus: A Consensus Algorithm For the Initiation and
Adjustment of Therapy, Diabetologia, 52, 17-30.

Ningtyas, 2013, Analisis Kualitas Hidup Pasien Diabetes Melitus tipe 2 RSUD
Bangil kabupaten 1-7.

Notoatmodjo, 2005, Metodologi Penelitian Kesehatan, Cetakan III, 92, Rineka

Cipta, Jakarta.

Nuryanti, I., dan Bantas, K., 2014, Prevalensi dan Faktor Risiko Kejadian Diabetes
Melitus pada Wanita Dewasa di Indonesia,
http://lontar.ui.ac.id/naskahringkas/2016-06/S55925-Irma%20Nuryanti, FKM
UI, Jakarta.

Papadopoulos, A,A., Kontodimopoulos, N., Frydas, A., Ikonomakis, E., Niakas, D.,
2007, Predictors of Health-Related Quality of Life in Type II Diabetic
Patients in Greece, BMC Public Health, 7 (186), 1 - 9.

PERKENI, 2006, Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus Tipe

2 di Indonesia, PB. PERKENI, Jakarta.

PERKENI, 2015, Konsensus Pengelolaan Dan Pencegahan Diabetes Melitus Tipe

2 di Indonesia, PB PERKENI, Jakarta.

Perwitasari, D.A., Urbayatun, S., Faridah, I.N., Masyithah, N., 2017, Relationship
of Therapeutic Outcome with Quality of Life on Type 2 Diabetes Mellitus
Patients in Abdul Azis Singkawang Hospital, IOP Conf. Ser.: Mater. Sci.
Eng. 259 012023.

Punthakee, Z., Goldenberg, R., Katz, P., 2018, Definition, Classification and
Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome, Can J
Diabetes., 42, 10–15.

Purba, F.D., Hunfeld, J. A. M., Iskandarsyah, A., Fitriana, T.S., Sadarjoen, S. S.,
Ramos-Gon, J. M., Passchier, J., Busschbach, J. J. V., 2017, The Indonesian
EQ-5D-5L Value Set, PharmacoEconomics, 35 (11), 1153–1165.
 Pengaruh Jenis Terapi, Outcome klinik dan Karakteristik Pasien terhadap Kualitas Hidup Pasien
Diabetes Melitus Tipe 2 di Rumah Sakit Pratama Yogyakarta 86
Monika Wisda Herisman, Dr. Tri Murti Andayani, Sp. FRS., Apt
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

Purba, F.D., Hunfeld, J. A. M., Iskandarsyah, A., Fitriana, T.S., Sadarjoen, S. S.,
Passchier, J., Busschbach, J. J. V., 2018, Quality of Life of the Indonesian
General Population: Test-Retest Reliability and Population Norms of the
EQ-5D-5L and WHOQOL-BREF, PLoS ONE, 13 (5), 1–20.

Purwaningsih, N., 2018, Analisis Faktor-Faktor Yang Mempengaruhi Kualitas

Hidup Pasien Diabetes Melitus Tipe 2 di Instalasi Rawat Jalan RSUD Dr.
Moewardi Periode Februari - Maret 2018, Skripsi, Universitas
Muhammadiyah Surakarta.

Price, S.A., and Wilson, L.M., 2005, Patofisiologi; Konsep Klinis Proses-Proses
Penyakit, Edisi 6, EGC, Jakarta.

Rabin, R. and de Charro, F., 2001, EQ-5D A Measure of Health Status from the
EuroQol Group, Annals of Medicine, 33, 337-343.

Rahajeng, E., 2004, Risiko Obesitas pada Kasus Toleransi Glukosaa Terganggu
terhadap Kejadian Diabetes Melitus Tipe 2 dan Faktor “Non genetik” Lain
yang Berhubungan, Jakarta, DEPKES RI cit. Nuryanti, I., dan Bantas, K.,
2014, Prevalensi dan Faktor Risiko Kejadian Diabetes Melitus pada Wanita
Dewasa di Indonesia, http://lontar.ui.ac.id/naskahringkas/2016-06/S55925-
Irma%20Nuryanti, 16 Mei 2019.

Rantung, J., Yetti, K., Herawati, T., 2015, Hubungan Self-care dengan Kualitas
Hidup Pasien Diabetes Melitus (DM) di Persatuan Diabetes Indonesia
(PERSADIA) Cabang Cimahi, Jurnal Skolastik Keperawatan, 1 (1), 38-51.

Rasdianah, 2016, Gambaran Kepatuhan Pengobatan Pasien Diabetes Melitus Tipe

2 di Puskesmas Daerah Istimewa Yogyakarta, Jurnal Farmasi Klinik
Indonesia, 5 (4), 249–257.

Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G.E.H.M.,

Wolffenbuttel, B. H. R., Niessen, L. W., 2002, Health-Related Quality of
Life and Treatment Satisfaction in Dutch Patient With Type 2 Diabetes,
Diabetes Care, 25, 458-463.

Reenen, M.V., & Janssen, B., 2015, EQ-5D-5L User Guide Basic information on
how to use the EQ-5D-5L instrument, EuroQoL Research Group,
Rotterdam.

Restada, E.J., 2016, Hubungan Lama Menderita dan Komplikasi Diabetes Melitus
dengan Kualitas Hidup pada Penerita Diabetes Melitus di Wilayah
Puskesmas Gatak Sukoharjo, Skripsi, Universitas Muhammadiyah
Surakarta.
 Pengaruh Jenis Terapi, Outcome klinik dan Karakteristik Pasien terhadap Kualitas Hidup Pasien
Diabetes Melitus Tipe 2 di Rumah Sakit Pratama Yogyakarta 87
Monika Wisda Herisman, Dr. Tri Murti Andayani, Sp. FRS., Apt
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

Rizkifani, 2014, Pengukuran Kualitas Hidup pasien Diabetes Melitus di Rumah

Sakit PKM Muhammadiah Bantul, Farmasains, 2 (3), 1-4.

Safita, N., Islam, S. M. S., Chow, C. K., Niessen, L., Lechner, A., Holle, R., Laxy,
M., 2016, The Impact of Type 2 Diabetes on Health Related Quality of Life
in Bangladesh: Results from Matched Study Comparing Treated Cases with
Non-diabetic Controls, Health and Quality of Life Outcomes, 14 (129), 1-9.

Safnurbaiti, D.P., Andayani, T.M., Irijanto, F., 2018, Analisis Biaya dan Nilai
Utilitas Pasien Hemodialisa yang diberikan Terapi Sevelamer Karbonat,
Oceana Biomedicina Journal, 1 (2), 79 – 89.

Sakamaki, H., Ikeda, S., Ikegami, N., Uchigata, Y., Iwamoto, Y., Origasa, H.,
Otani,T., Otani, Y., 2006, Measurement of HRQL Using EQ-5D in Patients
with Type 2 Diabetes Mellitus in Japan, International Society for
Pharmacoeconomics and Outcomes Research (ISPOR), 9 (1), 47–53.

Sari, R.M., Thobari, J.A., Andayani, T.M., 2011, Evaluasi Kualitas Hidup Pasien
Diabetes Melitus Tipe 2 yang di Terapi Rawat Jalan dengan Antidiabetik
Oral di RSUP Dr. Sardjito, Jurnal Manajemen dan Pelayanan Farmasi, 1
(1), 35-42.

Sari, 2017, Analisis Outcome Klinik, Kualitas Hidup, dan Biaya Terapi Pasien
Diabetes Melitus tipe 2, Thesis, Sekolah Pascasarjana Universitas Gadjah
Mada.

Saraswati, A.D., 2018, Hubungan Karakteristik Pasien dan Kepatuhan Berobat

terhadap Kualitas Hidup pada Pasien Diabetes Melitus tipe 2 di RSUD kota
Yogyakarta, Skripsi, Fakultas Farmasi Universitas Gadjah Mada.

Snoek, F.J., 2000, Quality of Life: A Closer Look at Measuring Patients’Well-

Being, cit. Trikkalinou, A., Papazafiropoulou, A.K., Melidonis, A., 2017,
Type 2 diabetes and quality of life, World J Diabetes, 8 (4), 120-129.

Soelistijo, S.A., et al., 2015, Konsensus Pengelolaan Dan Pencegahan Diabetes

Melitus Tipe 2 Di Indonesia 2015, Perkeni.

Solli, O., Stavem, K., Kristianse, I. S., 2010, Health-related quality of life in
diabetes: The associations of complications with EQ-5D scores, Health and
Quality of Life Outcomes, 8 (18), 1 – 8.

Spilker, B., 1996, Quality of Life and Pharmacoeconomisc in Clinical Ttrials, 2nd,
edition, 192-195, 517, Lippicott-Raven Publishers, Philadelphia.
 Pengaruh Jenis Terapi, Outcome klinik dan Karakteristik Pasien terhadap Kualitas Hidup Pasien
Diabetes Melitus Tipe 2 di Rumah Sakit Pratama Yogyakarta 88
Monika Wisda Herisman, Dr. Tri Murti Andayani, Sp. FRS., Apt
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

Stratton, I.M., et al., 2000, Association of glycemia with macrovascular and

microvascular complications of type 2 diabetes (UKPDS 35): prospective
observational study, BMJ, 321 (7258), 405-12.

Sukandar, E.Y., Andrajati, R., Sigit, J.I., Adnyana, I.K., Setiadi, A.P., Kusnandar,
2013, ISO Farmakoterapi, buku 1, ISFI Penerbitan Jakarta.

Suyono, S., 2004, Patofisiologi Diabetes Melitus, Editor: Soegondo, S., Soewondo,
P., Subekti, I., Diabetes Melitus Penatalaksanaan Terpadu, Cetakan ke-5,
Fakultas Kedokteran Universitas Indonesia, Jakarta.

Testa, M.A. and Simonson, D.C., 1996, Assesment of Quality of Life Outcomes,
(online), (http://www.erj.ersjournals.com/cgi/reprint/8/6/885.pdf, diakses 1
Mei 2018.

Tjandrawinata, R.R., 2016, Peran Farmakoekonomi dalam Penentuan Kebjakan

yang Berkaitan dengan Obat-Obatan., MEDICINUS, 29 (1), 46–52 cit.
Khoiriyah, S. D. & Lestari, K., 2018, Review Artikel: Kajian
Farmakoekonomi Yang Mendasari Pemilihan Pengobatan di Indonesia,
Farmaka., 16 (3), 134 – 145.

Tjay, T.H., dan Raharja, K., 2007, Obat-obat Penting (Khasiat Penggunaan dan
Efek-efek Sampingnya), Edisi VI, Cetakan Pertama, PT. Elex Media
Komputindo Kelompok Kompas-Gramedia, Jakarta.

Trikkalinou, A., Papazafiropoulou, A.K., Melidonis, A., 2017, Type 2 Diabetes and
Quality of Life, World J Diabetes, 8 (4), 120-129.

Triplitt, C.L., Reasner, C.A and Isley, W.L., 2005, Diabetes Mellitus, in Dipiro, J.T.
(eds), Pharmacotherapy A Pathophysiologic Approach, six ed, 1333-1368,
Appleton & Lange, Stanfor, Connecticute.

UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose

control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes (UKPDS
33), The Lancet, 352, 837-853.

Ulinur, M., 2018, Kualitas Hidup dan Faktor yang Mempengaruhi pada Pasien
Diabetes Melitus Tipe 2 di Rumah Sakit Umum Daerah Sleman, Skripsi,
Fakultas Farmasi Universitas Gadjah Mada.

Walling, A.D., 2002, Type 2 Diabetes Quality of Life and Early Insulin Therapy,
AFP, 65 (4) 707-8.
 Pengaruh Jenis Terapi, Outcome klinik dan Karakteristik Pasien terhadap Kualitas Hidup Pasien
Diabetes Melitus Tipe 2 di Rumah Sakit Pratama Yogyakarta 89
Monika Wisda Herisman, Dr. Tri Murti Andayani, Sp. FRS., Apt
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

Wahyuni, Y., Nursiswati, Anna, A., 2014, Kualitas Hidup Berdasarkan

Karakteristik Pasien Diabetes Melitus Tipe 2, Jurnal Keperawatan
Padjadjaran, 2 (1), 25-34.

Wahyuni, S. dan Alkaff, R. N., 2013, Diabetes Melitus pada Perempuan Usia
Reproduksi di Indonesia Tahun 2007, Jurnal Kesehatan Reproduksi, 3 (1),
46 – 51.

Wandell, P.E., 2005, Quality of Life of Patients with Diabetes Mellitus,

Scandinavian Journal of Primary Health Care, 23, 68-74.

World Health Organization (WHO), 2016, Global Report on Diabetes, Geneva.

Zeng, Y.C., Ching, S.S., and Loke, A.Y., 2010, Quality of Life Measurement in
Women with Cervical Cancer: Implications for Chinese Cervical Cancer
Survivors, Health and Quality of Life Outcomes, 8 (30), 1-9.

Zhang, P., Brown, M.D., Bilik, D., Ackermann, R.T., Li,R., Herman, W.H.,2012,
Health Utility Score for People with Type 2 Diabetes in U.S. Managed Care
Health Plans, Diabetes Care, 35 (11), 2250-2256.